Logo image of IBT.CA

IBEX TECHNOLOGIES INC (IBT.CA) Stock Price, Quote, News and Overview

TSX-V:IBT - TSX Venture Exchange - CA4489375085 - Common Stock - Currency: CAD

1.44  0 (0%)

IBT.CA Quote, Performance and Key Statistics

IBEX TECHNOLOGIES INC

TSX-V:IBT (4/5/2024, 7:00:00 PM)

1.44

0 (0%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High1.45
52 Week Low0.75
Market Cap35.30M
Shares24.51M
Float13.09M
Yearly DividendN/A
Dividend YieldN/A
PE9
Fwd PEN/A
Earnings (Next)12-15 2021-12-15
IPO11-14 1985-11-14


IBT.CA short term performance overview.The bars show the price performance of IBT.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40

IBT.CA long term performance overview.The bars show the price performance of IBT.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200 250

The current stock price of IBT.CA is 1.44 CAD. In the past month the price increased by 2.86%. In the past year, price increased by 89.47%.

IBEX TECHNOLOGIES INC / IBT Daily stock chart

IBT.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
FRX.CA FENNEC PHARMACEUTICALS INC N/A 310.73M
EDT.CA SPECTRAL MEDICAL INC N/A 236.65M
EPRX.CA EUPRAXIA PHARMACEUTICALS INC N/A 192.87M
TH.CA THERATECHNOLOGIES INC N/A 161.39M
MDNA.CA MEDICENNA THERAPEUTICS CORP N/A 75.09M
COV.CA COVALON TECHNOLOGIES LTD 14.18 66.08M
MSCL.CA SATELLOS BIOSCIENCE INC N/A 60.21M
BLU.CA BLUENERGIES LTD N/A 59.60M
HBP.CA HELIX BIOPHARMA CORP N/A 48.78M
MBX.CA MICROBIX BIOSYSTEMS INC 33 46.46M
SVA.CA SERNOVA BIOTHERAPEUTICS INC N/A 44.58M
ONC.CA ONCOLYTICS BIOTECH INC N/A 40.86M

About IBT.CA

Company Profile

IBT logo image IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The company is headquartered in Montreal, Quebec. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The firm also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The firm has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The firm operates in one industry segment: the production and sale of diagnostic products.

Company Info

IBEX TECHNOLOGIES INC

Suite 100, 5485 Pare Street

MONTREAL QUEBEC H4P 1P7 CA

CEO: Paul Baehr

Employees: 0

IBT Company Website

Phone: 15143444004

IBEX TECHNOLOGIES INC / IBT.CA FAQ

What is the stock price of IBEX TECHNOLOGIES INC today?

The current stock price of IBT.CA is 1.44 CAD.


What is the ticker symbol for IBEX TECHNOLOGIES INC stock?

The exchange symbol of IBEX TECHNOLOGIES INC is IBT and it is listed on the TSX Venture Exchange exchange.


On which exchange is IBT.CA stock listed?

IBT.CA stock is listed on the TSX Venture Exchange exchange.


What is IBEX TECHNOLOGIES INC worth?

IBEX TECHNOLOGIES INC (IBT.CA) has a market capitalization of 35.30M CAD. This makes IBT.CA a Nano Cap stock.


How many employees does IBEX TECHNOLOGIES INC have?

IBEX TECHNOLOGIES INC (IBT.CA) currently has 0 employees.


What are the support and resistance levels for IBEX TECHNOLOGIES INC (IBT.CA) stock?

IBEX TECHNOLOGIES INC (IBT.CA) has a support level at 1.43 and a resistance level at 1.45. Check the full technical report for a detailed analysis of IBT.CA support and resistance levels.


Should I buy IBEX TECHNOLOGIES INC (IBT.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does IBEX TECHNOLOGIES INC (IBT.CA) stock pay dividends?

IBT.CA does not pay a dividend.


When does IBEX TECHNOLOGIES INC (IBT.CA) report earnings?

IBEX TECHNOLOGIES INC (IBT.CA) will report earnings on 2021-12-15.


What is the Price/Earnings (PE) ratio of IBEX TECHNOLOGIES INC (IBT.CA)?

The PE ratio for IBEX TECHNOLOGIES INC (IBT.CA) is 9. This is based on the reported non-GAAP earnings per share of 0.16 and the current share price of 1.44 CAD. Check the full fundamental report for a full analysis of the valuation metrics for IBT.CA.


IBT.CA Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to IBT.CA. When comparing the yearly performance of all stocks, IBT.CA is one of the better performing stocks in the market, outperforming 94.53% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IBT.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to IBT.CA. Both the health and profitability get an excellent rating, making IBT.CA a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IBT.CA Financial Highlights

Over the last trailing twelve months IBT.CA reported a non-GAAP Earnings per Share(EPS) of 0.16. The EPS increased by 139.95% compared to the year before.


Industry RankSector Rank
PM (TTM) 51.82%
ROA 22.64%
ROE 28.25%
Debt/Equity 0.1
Chartmill High Growth Momentum
EPS Q2Q%20.09%
Sales Q2Q%17.51%
EPS 1Y (TTM)139.95%
Revenue 1Y (TTM)-0.82%

IBT.CA Ownership and Analysts


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A